Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: Group Dialectical Behavioural Therapy for Mood Instability Within Bipolar Disorder: An Open Trial
An open trial evaluating a group dialectical behavior therapy program for mood instability in bipolar disorder. The study aims to assess fea…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Using Motivational Techniques to Increase Levels of Physical Activity in Long Term Psychiatric Inpatient Wards
A completed clinical trial from Oslo University Hospital evaluated motivational techniques to increase physical activity levels among long-t…
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Evaluation of a Prevention Program in Children and Teenagers at High Risk for Bipolar Disorder (Bipokid) [NA]
The Bipokid trial evaluating a prevention program for children and adolescents at high risk for bipolar disorder has been terminated. The st…
-
CLINICAL_TRIALS research · 2018-05-11Clinical Trial Update: Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
A completed clinical trial examining the use of psychotropic medications among pregnant women with bipolar disorder.
-
FDA approval · 2018-05-03FDA Approved: LITHIUM CARBONATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for lithium carbonate filed by Glenmark Pharmaceuticals Inc., USA, authorizing changes to the pr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-05-03FDA Approved: LITHIUM CARBONATE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for lithium carbonate from Camber Pharmaceuticals, Inc. This approval represents an authorized chang…
-
CLINICAL_TRIALS trial_result · 2018-05-01Clinical Trial Update: Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression [Phase 2]
A Phase 2 trial of cariprazine in bipolar depression completed, with results on safety, tolerability, and efficacy posted in 2018.
-
FDA approval · 2018-04-30FDA Approved: LITHOBID — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for LITHOBID (lithium carbonate) by ANI Pharmaceuticals, Inc. under NDA 018027. The action represent…
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder [Phase 2]
Phase 2 trial evaluating N-acetylcysteine and aspirin as adjunctive treatment for bipolar disorder completed, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-04-27Clinical Trial Update: Nutrition, Exercise, and Wellness Treatment (NEW Tx) for Bipolar Disorder [Phase 1, Phase 2]
A clinical trial update reporting results for the Nutrition, Exercise, and Wellness Treatment (NEW Tx) in Bipolar Disorder across Phase 1 an…
-
FDA approval · 2018-04-18FDA Approved: ARIPIPRAZOLE — Original Application (Dr. Reddy's Laboratories Inc)
The FDA approved Dr. Reddy's Laboratories' generic aripiprazole orally disintegrating tablet through an original ANDA, enabling a generic ve…
-
CLINICAL_TRIALS trial_result · 2018-04-13Clinical Trial Update: Allopurinol Add-on Treatment for Refractory Mania [Phase 4]
Phase 4 trial exploring allopurinol as an add-on treatment for refractory mania in bipolar disorder has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: Daily Subjective and Objective Smartphone Measures of Illness Activity to Treat Bipolar Disorder- The MONARCA II Trial [NA]
The MONARCA II trial investigating daily smartphone-based measures for bipolar disorder has completed. Sponsor: Psychiatric Centre Rigshospi…
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Parents With Bipolar Disorder: Relationship of Adaptation to Own Illness With Risk Perception and Coping With Perceived Risk to a Child
This completed clinical study examined how parents with bipolar disorder adapt to their illness and how this adaptation relates to their per…
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: INCLUDE: Using Lived Experience to Improve Mental Health Diagnosis v1
This completed clinical trial evaluated the use of lived experience to improve mental health diagnosis. It covered conditions including depr…
-
CLINICAL_TRIALS trial_result · 2018-03-27Clinical Trial Update: Maintenance Transcranial Electrical Stimulation for Depression [NA]
This clinical trial update reports the completion of a study on maintenance transcranial electrical stimulation for depression in participan…
-
EMA guidance · 2018-03-23New measures to avoid valproate exposure in pregnancy endorsed
EU endorses new measures to avoid valproate exposure in pregnancy, reinforcing restrictions due to teratogenic risk.
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil [Phase 4]
Phase 4 clinical trial update evaluating modafinil for circadian and cognitive dysfunction in bipolar disorder has completed.
-
CLINICAL_TRIALS research · 2018-03-21Clinical Trial Update: Microbiome of Depression & Treatment Response to Citalopram
A completed Mayo Clinic trial studying how the microbiome relates to depression and response to citalopram treatment.
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolar Disorder [NA]
A terminated clinical trial studying side effects of antipsychotic medicines for treating childhood bipolar disorder; results posted in 2018…
-
FDA approval · 2018-03-20FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Tegretol (carbamazepine) from Novartis Pharmaceuticals Corporation.
-
FDA label_change · 2018-03-20FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Tegretol (carbamazepine) filed by Novartis Pharmaceuticals Corporation, updating the labelin…
-
CLINICAL_TRIALS trial_result · 2018-03-15Clinical Trial Update: Tranylcypromine Treatment of Bipolar Depression [Phase 4]
Phase 4 study of tranylcypromine for bipolar depression has completed, with results posted in 2018.
-
CLINICAL_TRIALS research · 2018-03-14Clinical Trial Update: Comparing Different Patterns of rTMS in Major Depression [NA]
This clinical trial update describes a study comparing different patterns of repetitive transcranial magnetic stimulation (rTMS) for major d…
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: Uridine Adolescent Bipolar Depression Randomized Controlled Trial [NA]
This ClinicalTrials.gov entry notes that the randomized controlled trial of uridine for adolescent bipolar depression completed and results …